All Stories

  1. Automated movement analysis predicts transition to non-psychotic disorders in individuals at ultra-high risk for psychosis
  2. Influence of migration on the thought process of individuals at ultra-high risk for psychosis
  3. Psychiatric neuroimaging research in Brazil: historical overview, current challenges, and future opportunities
  4. Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders
  5. Greater male than female variability in regional brain structure across the lifespan
  6. Relationship Between Symptomatic Dimensions and Global Functioning of Non–Help-Seeking Individuals at Risk for Psychosis
  7. Reproducibility in the absence of selective reporting: An illustration from large‐scale brain asymmetry research
  8. Plasma Metabolite Profiles in First Episode Psychosis: Exploring Symptoms Heterogeneity/Severity in Schizophrenia and Bipolar Disorder Cohorts
  9. Childhood maltreatment in individuals at risk of psychosis: Results from the Brazilian SSAPP cohort
  10. Brain aging in major depressive disorder: results from the ENIGMA major depressive disorder working group
  11. Efficacy and Safety of Transcranial Direct Current Stimulation for Treating Negative Symptoms in Schizophrenia
  12. “Fully automated habenula segmentation provides robust and reliable volume estimation across large MRI datasets suggesting intriguing developmental trajectories in psychiatric disease”
  13. An overlapping pattern of cerebral cortical thinning is associated with both positive symptoms and aggression in schizophrenia via the ENIGMA consortium
  14. Correction: Widespread white matter microstructural abnormalities in bipolar disorder: evidence from mega- and meta-analyses across 3033 individuals
  15. Widespread white matter microstructural abnormalities in bipolar disorder: evidence from mega- and meta-analyses across 3033 individuals
  16. Reduced Annexin A3 in schizophrenia
  17. Schizophrenia TreAtment with electRic Transcranial Stimulation (STARTS): design, rationale and objectives of a randomized, double-blinded, sham-controlled trial
  18. 10Kin1day: A Bottom-Up Neuroimaging Initiative
  19. Cocaine addiction and VBM methodological aspects.
  20. Reply to: New Meta- and Mega-analyses of Magnetic Resonance Imaging Findings in Schizophrenia: Do They Really Increase Our Knowledge About the Nature of the Disease Process?
  21. Plasma metabolites in first episode psychoses
  22. The role of neurocognitive functioning, substance use variables and the DSM-5 severity scale in cocaine relapse: A prospective study
  23. Hearing spirits? Religiosity in individuals at risk for psychosis—Results from the Brazilian SSAPP cohort
  24. Reply to: Sample Size, Model Robustness, and Classification Accuracy in Diagnostic Multivariate Neuroimaging Analyses
  25. HIGHER TRANSCRIPTION ALLELES OF THE MAOA-uVNTR POLYMORPHISM ARE ASSOCIATED WITH HIGHER SEIZURE FREQUENCY IN TEMPORAL LOBE EPILEPSY
  26. Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium
  27. BDNF Val66Met polymorphism is not related with temporal lobe epilepsy caused by hippocampal sclerosis in Brazilian population
  28. Genetic polymorphisms of the 5HT receptors are not related with depression in temporal lobe epilepsy caused by hippocampal sclerosis
  29. Mapping cortical brain asymmetry in 17,141 healthy individuals worldwide via the ENIGMA Consortium
  30. Increased platelet glycogen sysnthase kinase 3beta in first-episode psychosis
  31. T204. Treatment of Negative Symptoms of Schizophrenia With tDCS (Transcranial Direct Current Stimulation): A Randomized, Sham-Controlled, Double-Blinded Clinical Trial
  32. Association study of functional polymorphisms of dopaminergic pathway in epilepsy-related factors of temporal lobe epilepsy in Brazilian population
  33. Erratum
  34. T203. ILLICIT DRUGS USE AND ULTRA-HIGH RISK (UHR) FOR PSYCHOSIS STATUS IN A LATIN-AMERICAN SAMPLE
  35. Grey and white matter volumes either in treatment-naïve or hormone-treated transgender women: a voxel-based morphometry study
  36. Corpus callosum volumes in the 5 years following the first-episode of schizophrenia: Effects of antipsychotics, chronicity and maturation
  37. Neurobiological support to the diagnosis of ADHD in stimulant-naïve adults: pattern recognition analyses of MRI data
  38. Distinct cognitive performance and patterns of drug use among early and late onset cocaine users
  39. Detecting Neuroimaging Biomarkers for Depression: A Meta-analysis of Multivariate Pattern Recognition Studies
  40. State-dependent microstructural white matter changes in drug-naïve patients with first-episode psychosis
  41. Poverty, low education, and the expression of psychotic-like experiences in the general population of São Paulo, Brazil
  42. 897. Association between Childhood Adversity and Ultra-High Risk for Psychosis Status in a Populational Sample of Sao Paulo, Brazil
  43. High IQ May “Mask” the Diagnosis of ADHD by Compensating for Deficits in Executive Functions in Treatment-Naïve Adults With ADHD
  44. Lithium increases platelet serine-9 phosphorylated GSK-3β levels in drug-free bipolar disorder during depressive episodes
  45. Elevated neurotrophin-3 and neurotrophin 4/5 levels in unmedicated bipolar depression and the effects of lithium
  46. Multimodal Magnetic Resonance Imaging Study of Treatment-Naïve Adults with Attention-Deficit/Hyperactivity Disorder
  47. Neuroanatomical Classification in a Population-Based Sample of Psychotic Major Depression and Bipolar I Disorder with 1 Year of Diagnostic Stability
  48. Antipsychotic drugs decrease iPLA 2 gene expression in schizophrenia
  49. Corpus callosum volumes in recent-onset schizophrenia are correlated to positive symptom severity after 1year of follow-up
  50. Good surgical outcome in discordant ictal EEG-MRI unilateral mesial temporal sclerosis patients